Literature DB >> 7985647

Cigarette smoking: an independent risk factor for impotence?

D M Mannino1, R M Klevens, W D Flanders.   

Abstract

The authors sought to determine whether current cigarette smoking was associated with impotence among middle-aged men. This is a secondary analysis of a cross-sectional survey of 4,462 US Army Vietnam-era veterans aged 31-49 years who took part in the Vietnam Experience Study in 1985-1986. The main outcome measurement was the odds ratio for reported impotence, which was calculated by comparing current smokers with nonsmokers while controlling for multiple confounders. The study sample consisted of 1,162 never smokers, 1,292 former smokers, and 2,008 current smokers. The prevalence of impotence was 2.2% among never smokers, 2.0% among former smokers, and 3.7% among current smokers (p = 0.005). The unadjusted odds ratio (OR) of the association between smoking and reported impotence was 1.8 (95% confidence interval (CI) 1.2-2.6). The association held even after adjustments were made for confounders, including vascular disease, psychiatric disease, hormonal factors, substance abuse, marital status, race, and age (OR = 1.5, 95% CI 1.0-2.2). Neither years smoked nor cigarettes smoked daily were significant predictors of impotence in current smokers. The authors concluded that, among the men in this study, a higher percentage of cigarette smokers reported impotence than did nonsmokers. This observation could not be totally explained by comorbidity factors related to smoking.

Entities:  

Mesh:

Year:  1994        PMID: 7985647     DOI: 10.1093/oxfordjournals.aje.a117189

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  26 in total

Review 1.  Erectile dysfunction and atherosclerosis.

Authors:  Robert A Kloner; Mark Speakman
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.113

Review 2.  Prevalence of sexual dysfunctions: results from a decade of research.

Authors:  J S Simons; M P Carey
Journal:  Arch Sex Behav       Date:  2001-04

3.  Association between smoking cessation and sexual health in men.

Authors:  Christopher B Harte; Cindy M Meston
Journal:  BJU Int       Date:  2011-08-23       Impact factor: 5.588

4.  Prevalence and factors associated with erectile dysfunction in patients with chronic kidney disease on conservative treatment.

Authors:  M R Costa; V C Ponciano; T R Costa; A M de Oliveira; C P Gomes; E C de Oliveira
Journal:  Int J Impot Res       Date:  2017-04-20       Impact factor: 2.896

Review 5.  Mitochondrial toxicity of tobacco smoke and air pollution.

Authors:  Jessica L Fetterman; Melissa J Sammy; Scott W Ballinger
Journal:  Toxicology       Date:  2017-08-22       Impact factor: 4.221

6.  Effect of a Smoking Cessation Program on Sexual Function Recovery Following Robotic Prostatectomy at Kaiser Permanente Southern California.

Authors:  Seena Safavy; Patrick S Kilday; Jeff M Slezak; George A Abdelsayed; Teresa N Harrison; Steven J Jacobsen; Gary W Chien
Journal:  Perm J       Date:  2017

7.  Smoking and erectile dysfunction: findings from a representative sample of Australian men.

Authors:  C Millett; L M Wen; C Rissel; A Smith; J Richters; A Grulich; R de Visser
Journal:  Tob Control       Date:  2006-04       Impact factor: 7.552

Review 8.  Evaluation and Management of Erectile Dysfunction in the Hypertensive Patient.

Authors:  Jay Pravin Patel; Eric Hweegeun Lee; Carlos Ignacio Mena-Hurtado; Charles N Walker
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

9.  The effect of cigarette smoking on musculoskeletal-related disability.

Authors:  Andrew E Lincoln; Gordon S Smith; Paul J Amoroso; Nicole S Bell
Journal:  Am J Ind Med       Date:  2003-04       Impact factor: 2.214

10.  The inhibitory effects of nicotine on physiological sexual arousal in nonsmoking women: results from a randomized, double-blind, placebo-controlled, cross-over trial.

Authors:  Christopher B Harte; Cindy M Meston
Journal:  J Sex Med       Date:  2008-03-04       Impact factor: 3.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.